1299 related articles for article (PubMed ID: 22469599)
21. Rhinosinusitis: Developing guidance for clinical trials.
Meltzer EO; Hamilos DL; Hadley JA; Lanza DC; Marple BF; Nicklas RA; Adinoff AD; Bachert C; Borish L; Chinchilli VM; Danzig MR; Ferguson BJ; Fokkens WJ; Jenkins SG; Lund VJ; Mafee MF; Naclerio RM; Pawankar R; Ponikau JU; Schubert MS; Slavin RG; Stewart MG; Togias A; Wald ER; Winther B;
Otolaryngol Head Neck Surg; 2006 Nov; 135(5 Suppl):S31-80. PubMed ID: 17081855
[TBL] [Abstract][Full Text] [Related]
22. [Polypous rhinosinusitis].
Poliakova TS; Bondareva GP; Cheliadinova EV
Vestn Otorinolaringol; 1998; (2):52-6. PubMed ID: 9560988
[No Abstract] [Full Text] [Related]
23. European position paper on rhinosinusitis and nasal polyps.
European Academy of Allergology and Clinical Immunology
Rhinol Suppl; 2005; 18():1-87. PubMed ID: 15847064
[No Abstract] [Full Text] [Related]
24. Nasal polyps and rhinosinusitis.
Kwah JH; Peters AT
Allergy Asthma Proc; 2019 Nov; 40(6):380-384. PubMed ID: 31690375
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory infiltrate and mucosal remodeling in chronic rhinosinusitis with and without polyps: structured histopathologic analysis.
Kuhar HN; Tajudeen BA; Mahdavinia M; Gattuso P; Ghai R; Batra PS
Int Forum Allergy Rhinol; 2017 Jul; 7(7):679-689. PubMed ID: 28521083
[TBL] [Abstract][Full Text] [Related]
26. Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps.
Caminati M; De Corso E; Ottaviano G; Pipolo C; Schiappoli M; Seccia V; Spinelli FR; Savarino EV; Gisondi P; Senna G
Curr Allergy Asthma Rep; 2024 Jan; 24(1):11-23. PubMed ID: 38085499
[TBL] [Abstract][Full Text] [Related]
27. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management.
Bachert C; Han JK; Wagenmann M; Hosemann W; Lee SE; Backer V; Mullol J; Gevaert P; Klimek L; Prokopakis E; Knill A; Cavaliere C; Hopkins C; Hellings P
J Allergy Clin Immunol; 2021 Jan; 147(1):29-36. PubMed ID: 33227318
[TBL] [Abstract][Full Text] [Related]
28. European position paper on rhinosinusitis and nasal polyps 2007.
Fokkens W; Lund V; Mullol J;
Rhinol Suppl; 2007; 20():1-136. PubMed ID: 17844873
[TBL] [Abstract][Full Text] [Related]
29. [The preliminary analysis of chronic rhinosinusitis: clinical phenotypes and inflammation features].
Bai Y; Ao YY; Xu C; Qiu X; Zhang Y; Wang HT
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):107-110. PubMed ID: 29871198
[No Abstract] [Full Text] [Related]
30. Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies.
Poto R; Pelaia C; di Salvatore A; Saleh H; Scadding GW; Varricchi G
Curr Opin Allergy Clin Immunol; 2024 Aug; 24(4):243-250. PubMed ID: 38205820
[TBL] [Abstract][Full Text] [Related]
31. Canadian guidelines for chronic rhinosinusitis: Clinical summary.
Kaplan A
Can Fam Physician; 2013 Dec; 59(12):1275-81, e528-34. PubMed ID: 24336538
[TBL] [Abstract][Full Text] [Related]
32. Executive summary of EPOS 2020 including integrated care pathways.
Fokkens WJ; Lund VJ; Hopkins C; Hellings PW; Kern R; Reitsma S; Toppila-Salmi S; Bernal-Sprekelsen M; Mullol J
Rhinology; 2020 Apr; 58(2):82-111. PubMed ID: 32226949
[TBL] [Abstract][Full Text] [Related]
33. Refractory Chronic Rhinosinusitis with Nasal Polyposis.
Hull BP; Chandra RK
Otolaryngol Clin North Am; 2017 Feb; 50(1):61-81. PubMed ID: 27888916
[TBL] [Abstract][Full Text] [Related]
34. Chronic rhinosinusitis with and without nasal polyps: what is the difference?
Huvenne W; van Bruaene N; Zhang N; van Zele T; Patou J; Gevaert P; Claeys S; Van Cauwenberge P; Bachert C
Curr Allergy Asthma Rep; 2009 May; 9(3):213-20. PubMed ID: 19348721
[TBL] [Abstract][Full Text] [Related]
35. Distinguishing Molecular Features of Allergic Fungal Rhinosinusitis.
Tyler MA; Padro Dietz CJ; Russell CB; Citardi MJ; Assassi S; Ying J; Luong AU
Otolaryngol Head Neck Surg; 2018 Jul; 159(1):185-193. PubMed ID: 29584543
[TBL] [Abstract][Full Text] [Related]
36. [Management strategies for chronic rhinosinusitis with nasal polyps].
Leggewie B; Gabrielpillai J; Strieth S
HNO; 2022 Jan; 70(1):79-86. PubMed ID: 34994808
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology and differential diagnosis of nasal polyps.
Chaaban MR; Walsh EM; Woodworth BA
Am J Rhinol Allergy; 2013; 27(6):473-8. PubMed ID: 24274222
[TBL] [Abstract][Full Text] [Related]
38. Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps.
van der Lans R; Otten JJ; Adriaensen GFJPM; Benoist LBL; Cornet ME; Hoven DR; Rinia AB; Fokkens WJ; Reitsma S
Rhinology; 2024 Jun; 62(3):383-384. PubMed ID: 38478151
[TBL] [Abstract][Full Text] [Related]
39. Surfactant proteins A and D are related to severity of the disease, pathogenic bacteria and comorbidity in patients with chronic rhinosinusitis with and without nasal polyps.
Uhliarova B; Kopincova J; Adamkov M; Svec M; Calkovska A
Clin Otolaryngol; 2016 Jun; 41(3):249-58. PubMed ID: 26220138
[TBL] [Abstract][Full Text] [Related]
40. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
Mullol J; Picado C
Immunol Allergy Clin North Am; 2013 May; 33(2):163-76. PubMed ID: 23639706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
